Clincosm LogoSign in Get a demo

Overweight

Showing NaN - NaN of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Pelham, Alabama
  • +69 more
Oct 5, 2021

Obesity, Nutrition Disorders, Overweight Trial in Dallas (Micafungin)

Completed
Has Results
  • Obesity
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Nov 2, 2020

Primary Care, Communication, and Improving Children's Health

Completed
  • Childhood Obesity
  • +3 more
  • Communication regarding overweight status
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern and Children's Medical Center
May 15, 2020

Primary Care Clinical Practice Elements and Improving Overweight

Completed
  • Overweight
  • Childhood Obesity
  • Attention to BMI
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern and Children's Medical Center
May 15, 2020

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

Terminated
Has Results
  • Obesity
  • Overweight
  • Birmingham, Alabama
  • +223 more
Feb 24, 2017

Obesity, Overweight Trial in United States (NB, CLI, Usual Care)

Completed
Has Results
  • Obesity
  • Overweight
  • Denver, Colorado
  • +14 more
Nov 30, 2015

Overweight Trial in Dallas, Madison (RM-493, Placebo)

Completed
  • Overweight
  • Dallas, Texas
  • +1 more
Apr 13, 2015

Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)

Completed
Has Results
  • Overweight
  • Obesity
  • pramlintide acetate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Mar 26, 2015

Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary

Completed
Has Results
  • Obesity
  • +2 more
  • Naltrexone SR 32 mg/bupropion SR 360 mg/ day
  • +2 more
  • Fairhope, Alabama
  • +52 more
Nov 18, 2014

Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360

Completed
Has Results
  • Obesity
  • Overweight
  • Naltrexone SR 16 mg/Bupropion SR 360 mg /day
  • +3 more
  • Birmingham, Alabama
  • +33 more
Nov 18, 2014

Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, Ancillary therapy)

Completed
Has Results
  • Obesity
  • Overweight
  • Naltrexone SR 32 mg/bupropion SR 360 mg/day
  • +2 more
  • Phoenix, Arizona
  • +35 more
Nov 18, 2014

Type 2 Diabetes, Overweight, Obesity Trial in United States (Weight Watchers modified program, Standard Care group)

Completed
  • Type 2 Diabetes
  • +2 more
  • Weight Watchers modified program
  • Standard Care group
  • Birmingham, Alabama
  • +14 more
Oct 14, 2014

Diabetes, Overweight Trial in United States (vegan instruction and food accessibility, control)

Completed
  • Diabetes
  • Overweight
  • vegan instruction and food accessibility
  • control
  • Tucson, Arizona
  • +9 more
Jan 23, 2013